WHO ICTRP trial
A phase I clinical trial for the tolerability of CT102 for injection in the…
ChiCTR2100044235 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100044235 |
|---|---|
| Public title | A phase I clinical trial for the tolerability of CT102 for injection in the treatment of primary hepatocellular carcinoma |
| Scientific title | A phase I clinical trial for the tolerability of CT102 for injection in the treatment of primary hepatocellular carcinoma |
| Primary sponsor | The Fifth Medical Center of Chinese PLA General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Primary hepatocellular carcinoma |
| Interventions | CT102 Group:single-dose CT102 |
| Registration date | Mar 12, 2021 |
| Target size | CT102 Group:36 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: